SCHEMBL25958451

SCHEMBL25958451

Cc1ccc(NC(=O)c2cnn(CS(C)(=O)=O)n2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 6/20 0.41
KDR P35968 6/20 0.41
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
LMNA P02545 3/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.39
MRGPRX1 Q96LB2 2/20 0.39
HRH1 P35367 1/20 0.39
SCN9A Q15858 1/20 0.38
TSHR P16473 1/20 0.38
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25960149 0.90 TSHR (0.48) ALDH1A1POLBLMNANPC1RAB9A
SCHEMBL25958445 0.88 RAB9A (0.46) POLBLMNANPC1RAB9ASMN1; SMN2
SCHEMBL25958714 0.84 LMNA (0.42) FLT1KDRALDH1A1POLBLMNA
SCHEMBL25958429 0.83 FLT1 (0.41) FLT1KDRALDH1A1POLBLMNA
SCHEMBL25960133 0.82 ALOX15 (0.47) LMNAKMT2A
SCHEMBL25958443 0.81 NPC1 (0.44) FLT1KDRLMNANPC1RAB9A
SCHEMBL25958438 0.81 FLT1 (0.42) FLT1KDRALDH1A1POLBLMNA
SCHEMBL25958280 0.81 FLT1 (0.42) FLT1KDRALDH1A1POLBLMNA
SCHEMBL25958453 0.81 KDR (0.44) FLT1KDRLMNANPC1RAB9A
SCHEMBL25960137 0.80 CYP1A2 (0.48) ALDH1A1POLBLMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME ALOX15, ALOX5, ALOX15B FLT1 2205/4885KDR 2706/4885ALDH1A1 401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.